Pacific Biosciences of California, Inc. Selling, General and Administrative Expense
Pacific Biosciences of California, Inc. (PACB) reported Selling, General and Administrative Expense of $33.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- Pacific Biosciences of California, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $33.39M, a 7.69% decline year-over-year.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $31.15M, a 22.44% decline year-over-year.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $34.05M, a 18.23% decline year-over-year.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $31.10M, a 28.91% decline year-over-year.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for fiscal 2025 was $141.49M, a 19.15% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for fiscal 2024 was $175.02M, a 3.06% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for fiscal 2023 was $169.82M, a 5.57% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. selling, general and administrative expense for fiscal 2022 was $160.85M, a 29.59% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.39M 10-Q · filed 2026-08-06 | $64.55M 10-Q · filed 2026-08-06 | $98.60M derived: sum of 3 quarters · filed 2026-08-06 | $129.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $31.15M 10-Q · filed 2026-05-08 | $65.20M derived: sum of 2 quarters · filed 2026-05-08 | $96.30M derived: sum of 3 quarters · filed 2026-05-08 | $132.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $34.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $65.15M derived: sum of 2 quarters · filed 2026-02-25 | $101.33M derived: sum of 3 quarters · filed 2026-08-06 | $141.49M 10-K · filed 2026-02-25 |
| 2025-09-30 | $31.10M 10-Q · filed 2025-11-06 | $67.27M derived: sum of 2 quarters · filed 2026-08-06 | $107.44M 10-Q · filed 2025-11-06 | $149.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $36.17M 10-Q · filed 2026-08-06 | $76.34M 10-Q · filed 2026-08-06 | $117.98M derived: sum of 3 quarters · filed 2026-08-06 | $161.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $40.17M 10-Q · filed 2026-05-08 | $81.81M derived: sum of 2 quarters · filed 2026-05-08 | $125.56M derived: sum of 3 quarters · filed 2026-05-08 | $171.43M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $41.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $85.39M derived: sum of 2 quarters · filed 2026-02-25 | $131.26M derived: sum of 3 quarters · filed 2026-02-25 | $175.02M 10-K · filed 2026-02-25 |
| 2024-09-30 | $43.75M 10-Q · filed 2025-11-06 | $89.62M derived: sum of 2 quarters · filed 2025-11-06 | $133.38M 10-Q · filed 2025-11-06 | $179.37M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $45.88M 10-Q · filed 2025-08-07 | $89.63M 10-Q · filed 2025-08-07 | $135.63M derived: sum of 3 quarters · filed 2026-02-25 | $179.06M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $43.75M 10-Q · filed 2025-05-12 | $89.75M derived: sum of 2 quarters · filed 2026-02-25 | $133.18M derived: sum of 3 quarters · filed 2026-02-25 | $173.75M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $89.43M derived: sum of 2 quarters · filed 2026-02-25 | $130.00M derived: sum of 3 quarters · filed 2026-02-25 | $169.82M 10-K · filed 2026-02-25 |
| 2023-09-30 | $43.43M 10-Q · filed 2024-11-12 | $84.00M derived: sum of 2 quarters · filed 2024-11-12 | $123.82M 10-Q · filed 2024-11-12 | $168.82M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $40.57M 10-Q · filed 2024-08-09 | $80.39M 10-Q · filed 2024-08-09 | $125.39M derived: sum of 3 quarters · filed 2025-03-17 | $162.19M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $39.82M 10-Q · filed 2024-05-09 | $84.82M derived: sum of 2 quarters · filed 2025-03-17 | $121.62M derived: sum of 3 quarters · filed 2025-03-17 | $160.87M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $81.80M derived: sum of 2 quarters · filed 2025-03-17 | $121.05M derived: sum of 3 quarters · filed 2025-03-17 | $160.85M 10-K · filed 2025-03-17 |
| 2022-09-30 | $36.80M 10-Q · filed 2023-11-03 | $76.05M derived: sum of 2 quarters · filed 2023-11-03 | $115.85M 10-Q · filed 2023-11-03 | $153.17M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $39.25M 10-Q · filed 2023-08-04 | $79.06M 10-Q · filed 2023-08-04 | $116.38M derived: sum of 3 quarters · filed 2024-02-28 | $147.98M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $39.80M 10-Q · filed 2023-05-04 | $77.12M derived: sum of 2 quarters · filed 2024-02-28 | $108.73M derived: sum of 3 quarters · filed 2024-02-28 | $137.79M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $37.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $68.93M derived: sum of 2 quarters · filed 2024-02-28 | $97.99M derived: sum of 3 quarters · filed 2024-02-28 | $124.12M 10-K · filed 2024-02-28 |
| 2021-09-30 | $31.61M 10-Q · filed 2022-11-08 | $60.67M derived: sum of 2 quarters · filed 2022-11-08 | $86.80M 10-Q · filed 2022-11-08 | $104.76M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $29.06M 10-Q · filed 2022-08-08 | $55.20M 10-Q · filed 2022-08-08 | $73.15M derived: sum of 3 quarters · filed 2023-02-28 | $87.92M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $26.14M 10-Q · filed 2022-05-06 | $44.09M derived: sum of 2 quarters · filed 2023-02-28 | $58.86M derived: sum of 3 quarters · filed 2023-02-28 | $73.99M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $32.73M derived: sum of 2 quarters · filed 2023-02-28 | $47.85M derived: sum of 3 quarters · filed 2023-02-28 | $72.80M 10-K · filed 2023-02-28 |
| 2020-09-30 | $14.77M 10-Q · filed 2021-11-05 | $29.90M derived: sum of 2 quarters · filed 2021-11-05 | $54.85M 10-Q · filed 2021-11-05 | $71.42M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $15.13M 10-Q · filed 2021-08-06 | $40.07M 10-Q · filed 2021-08-06 | $56.65M derived: sum of 3 quarters · filed 2022-02-28 | $76.72M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $24.95M 10-Q · filed 2021-05-06 | $41.52M derived: sum of 2 quarters · filed 2022-02-28 | $61.59M derived: sum of 3 quarters · filed 2022-02-28 | $80.67M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $16.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $36.64M derived: sum of 2 quarters · filed 2022-02-28 | $55.73M derived: sum of 3 quarters · filed 2022-02-28 | $75.49M 10-K · filed 2022-02-28 |
| 2019-09-30 | $20.07M 10-Q · filed 2020-11-03 | $39.15M derived: sum of 2 quarters · filed 2020-11-03 | $58.91M 10-Q · filed 2020-11-03 | $79.02M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $19.08M 10-Q · filed 2020-08-06 | $38.85M 10-Q · filed 2020-08-06 | $58.95M derived: sum of 3 quarters · filed 2021-02-26 | $72.46M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $19.77M 10-Q · filed 2020-05-08 | $39.87M derived: sum of 2 quarters · filed 2021-02-26 | $53.38M derived: sum of 3 quarters · filed 2021-02-26 | $68.32M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $20.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $33.61M derived: sum of 2 quarters · filed 2021-02-26 | $48.55M derived: sum of 3 quarters · filed 2021-02-26 | $63.49M 10-K · filed 2021-02-26 |
| 2018-09-30 | $13.51M 10-Q · filed 2019-11-07 | $28.45M derived: sum of 2 quarters · filed 2019-11-07 | $43.38M 10-Q · filed 2019-11-07 | $57.78M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $14.94M 10-Q · filed 2019-08-06 | $29.88M 10-Q · filed 2019-08-06 | $44.27M derived: sum of 3 quarters · filed 2020-02-28 | $58.23M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $14.93M 10-Q · filed 2019-05-03 | $29.33M derived: sum of 2 quarters · filed 2020-02-28 | $43.28M derived: sum of 3 quarters · filed 2020-02-28 | $58.79M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $28.35M derived: sum of 2 quarters · filed 2020-02-28 | $43.85M derived: sum of 3 quarters · filed 2020-02-28 | $59.12M 10-K · filed 2020-02-28 |
| 2017-09-30 | $13.95M 10-Q · filed 2018-11-05 | $29.46M derived: sum of 2 quarters · filed 2018-11-05 | $44.72M 10-Q · filed 2018-11-05 | $57.72M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $15.51M 10-Q · filed 2018-08-03 | $30.77M 10-Q · filed 2018-08-03 | $43.76M derived: sum of 3 quarters · filed 2019-02-26 | $55.66M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $15.27M 10-Q · filed 2018-05-02 | $28.26M derived: sum of 2 quarters · filed 2019-02-26 | $40.15M derived: sum of 3 quarters · filed 2019-02-26 | $51.34M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $24.89M derived: sum of 2 quarters · filed 2019-02-26 | $36.08M derived: sum of 3 quarters · filed 2019-02-26 | $47.79M 10-K · filed 2019-02-26 |
| 2016-09-30 | $11.89M 10-Q · filed 2017-11-02 | $23.09M derived: sum of 2 quarters · filed 2017-11-02 | $34.79M 10-Q · filed 2017-11-02 | $47.57M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $11.19M 10-Q · filed 2017-08-02 | $22.90M 10-Q · filed 2017-08-02 | $35.68M derived: sum of 3 quarters · filed 2018-02-26 | $46.49M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $11.71M 10-Q · filed 2017-05-05 | $24.48M derived: sum of 2 quarters · filed 2018-02-26 | $35.30M derived: sum of 3 quarters · filed 2018-02-26 | $46.12M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $12.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $23.59M derived: sum of 2 quarters · filed 2018-02-26 | $34.41M derived: sum of 3 quarters · filed 2018-02-26 | $45.19M 10-K · filed 2018-02-26 |
| 2015-09-30 | $10.82M 10-Q · filed 2016-11-04 | $21.64M derived: sum of 2 quarters · filed 2016-11-04 | $32.41M 10-Q · filed 2016-11-04 | $42.41M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $10.82M 10-Q · filed 2016-08-04 | $21.59M 10-Q · filed 2016-08-04 | $31.59M derived: sum of 3 quarters · filed 2017-03-06 | $41.48M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $10.77M 10-Q · filed 2016-05-05 | $20.77M derived: sum of 2 quarters · filed 2017-03-06 | $30.66M derived: sum of 3 quarters · filed 2017-03-06 | $39.65M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $19.88M derived: sum of 2 quarters · filed 2017-03-06 | $28.88M derived: sum of 3 quarters · filed 2017-03-06 | $38.03M 10-K · filed 2017-03-06 |
| 2014-09-30 | $9.88M 10-Q · filed 2015-11-05 | $18.88M derived: sum of 2 quarters · filed 2015-11-05 | $28.02M 10-Q · filed 2015-11-05 | $37.09M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $8.99M 10-Q · filed 2015-08-05 | $18.14M 10-Q · filed 2015-08-05 | $27.20M derived: sum of 3 quarters · filed 2016-03-11 | $37.96M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $9.15M 10-Q · filed 2015-05-05 | $18.21M derived: sum of 2 quarters · filed 2016-03-11 | $28.97M derived: sum of 3 quarters · filed 2016-03-11 | $38.34M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $19.82M derived: sum of 2 quarters · filed 2016-03-11 | $29.19M derived: sum of 3 quarters · filed 2016-03-11 | $38.74M 10-K · filed 2016-03-11 |
| 2013-09-30 | $10.76M 10-Q · filed 2014-11-05 | $20.13M derived: sum of 2 quarters · filed 2014-11-05 | $29.68M 10-Q · filed 2014-11-05 | $40.35M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $9.37M 10-Q · filed 2014-08-05 | $18.93M 10-Q · filed 2014-08-05 | $29.60M derived: sum of 3 quarters · filed 2015-03-12 | $39.74M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $9.55M 10-Q · filed 2014-05-08 | $20.22M derived: sum of 2 quarters · filed 2015-03-12 | $30.37M derived: sum of 3 quarters · filed 2015-03-12 | $41.92M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $10.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $20.81M derived: sum of 2 quarters · filed 2015-03-12 | $32.37M derived: sum of 3 quarters · filed 2015-03-12 | $47.66M 10-K · filed 2015-03-12 |
| 2012-09-30 | $10.14M 10-Q · filed 2013-11-12 | $21.70M derived: sum of 2 quarters · filed 2013-11-12 | $36.99M 10-Q · filed 2013-11-12 | $48.80M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $11.56M 10-Q · filed 2013-08-09 | $26.84M 10-Q · filed 2013-08-09 | $38.65M derived: sum of 3 quarters · filed 2014-03-14 | $51.42M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $15.29M 10-Q · filed 2013-05-10 | $27.10M derived: sum of 2 quarters · filed 2014-03-14 | $39.86M derived: sum of 3 quarters · filed 2014-03-14 | $50.88M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $24.57M derived: sum of 2 quarters · filed 2014-03-14 | $35.59M derived: sum of 3 quarters · filed 2014-03-14 | $46.71M 10-K · filed 2014-03-14 |
| 2011-09-30 | $12.76M 10-Q · filed 2012-11-01 | $23.78M derived: sum of 2 quarters · filed 2012-11-01 | $34.90M 10-Q · filed 2012-11-01 | $45.23M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $11.02M 10-Q · filed 2012-08-07 | $22.14M 10-Q · filed 2012-08-07 | $32.46M derived: sum of 3 quarters · filed 2013-03-15 | $40.51M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $11.12M 10-Q · filed 2012-05-07 | $21.45M derived: sum of 2 quarters · filed 2013-03-15 | $29.49M derived: sum of 3 quarters · filed 2013-03-15 | $35.71M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $18.37M derived: sum of 2 quarters · filed 2013-03-15 | $24.59M derived: sum of 3 quarters · filed 2013-03-15 | $30.09M 10-K · filed 2013-03-15 |
| 2010-09-30 | $8.04M 10-Q · filed 2011-11-14 | $14.27M derived: sum of 2 quarters · filed 2011-11-14 | $19.76M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $6.22M 10-Q · filed 2011-08-12 | $11.72M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $12.33M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |